Quest Diagnostics: Post-COVID Normalization Pretty Much Done

AzmanJaka Investment Thesis Quest Diagnostics (NYSE:DGX) is an exceptionally stable company that operates a fantastic business. Over the last 10 years, its total return has exceeded that of the S&P500, and in the last 20 years, its shares have never fallen by more than 36%, even during the crises of 2008 and 2020. This fact underscores the resilience and strength of the business. However, in 2020, the company benefited from COVID-19 testing, which atypically boosted growth and margins, leading to an ove ...